[Adult acute lymphoblastic leukemia - 20-year treatment results at TYKS]

Duodecim. 2014;130(7):714-20.
[Article in Finnish]

Abstract

Approximately 30 cases of adult acute lymphoblastic leukemia (ALL) emerge in Finland yearly. In literature 35 to 40% of those under the age of 60 are reported to recover from their illness. Of the 67 adult ALL patients treated at the Turku University Hospital from 1990 to 2010, 96% achieved remission. The five-year survival rate was 53%. After remission, an allogeneic stem cell transplant was performed for 22 patients (37%), with 38 patients (63%) continuing on cytotoxic drugs. There was no difference in survival between modes of treatment or risk groups.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Combined Modality Therapy
  • Female
  • Finland / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / epidemiology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Prognosis
  • Remission Induction
  • Stem Cell Transplantation
  • Survival Rate
  • Treatment Outcome

Substances

  • Antineoplastic Agents